Haemonetics Corporation

NYSE:HAE

Medical - Instruments & Supplies

Healthcare
$122.86 +1.15%

+$0.84 today

Market cap
$5.59B
Beta
0.54
P/E (TTM)
34.9
EPS (TTM)
$2.11
52W Low $47.32High $87.32

Volume 0.48M

Average 0.88M

HAE Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Haemonetics CorporationNYSE: HAE

Weighted Avg Shares · Q1 FY2027 · quarter ended Jun 2026

Weighted avg shares declines year over year

Q1 FY2027 weighted avg shares of 45.36M shares fell 5.7% year over year, ahead of the -6.3% change in trailing-twelve-month weighted avg shares. Sequentially, it fell 1.9% from the prior quarter. Over 3 fiscal years it compounded at -2.4% a year.

Context

  • Weighted avg shares increased in 0 of the last 3 fiscal years.
  • FY2026 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of -5.7% holds above the trailing-twelve-month pace of -6.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
45.36M-1.9% QoQ
Last fiscal yearMar 2026
47.18M-6.3% YoY
LTMJun 2026
46.49M-6.3% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-5.7%——
1 year-6.3%——
3-year CAGR-2.4%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2026
47.18M USD
Year-over-year change
-6.3%
4-year CAGR
-2.0%

Weighted Avg Shares vs competitors

How HAE compares with its peers on the latest reported figures

  • HAE's LTM Jun 2026 weighted avg shares of 46.49M shares is the 8th highest of the 10 companies compared; the peer median is 122.33M shares.
  • Its year-over-year change of -6.3% is the lowest of 10, against a peer median of +1.0%.
  • Over three fiscal years its annual growth of -2.4% compares with a peer median of +1.6%.
HAE Competitors Peer median
Weighted Avg Shares for HAE and competitors
Company Period LTM YoY 3-year CAGR
BHCBausch Health Companies Inc.LTM Jun 2026372.41M +0.6%+0.8%
XRAYDENTSPLY SIRONA Inc.LTM Mar 2026199.58M -1.3%-2.6%
CONConcentra Group Holdings Parent, Inc.LTM Sep 2026126.76M -0.2%+0.0%
WRBYWarby Parker Inc.LTM Jun 2026123.27M +1.3%+2.2%
CPRXCatalyst Pharmaceuticals, Inc.LTM Mar 2026122.33M +2.3%+5.8%
BEAMBeam Therapeutics Inc.LTM Jun 2026103.26M +16.4%+12.2%
QDELQuidelOrtho CorporationLTM Mar 202667.93M +1.0%+6.1%
HAEHaemonetics CorporationLTM Jun 202646.49M -6.3%-2.4%
ITGRInteger Holdings CorporationLTM Jul 202634.56M +1.4%+1.6%
LMATLeMaitre Vascular, Inc.LTM Mar 202622.7M +0.9%+1.0%
Peer median (excluding HAE) 122.33M+1.0%+1.6%

Competitors are the stored peer set for HAE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Mar 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Revenue993.2M1.17B1.31B1.36B1.33B
Cost of Revenue462.43M545.79M597.14M582.28M590.44M
Gross Profit530.77M622.87M711.92M778.55M743.59M
Gross Margin53.4%53.3%54.4%57.2%55.7%
Research & Development55.2M58.63M63.04M69.42M59.77M
Selling, General & Admin332.2M373.95M420.82M422.05M442.42M
Operating Expenses450.02M466.84M547.03M556.73M502.19M
Depreciation & Amortization97.75M93.31M97.22M115.59M111.72M
EBITDA202.92M260.51M304.05M362.69M268.45M
EBITDA Margin20.4%22.3%23.2%26.7%20.1%
Operating Income80.75M156.03M164.88M221.82M241.4M
Operating Margin8.1%13.4%12.6%16.3%18.1%
Interest Income00000
Interest Expense17.12M14.63M13.02M9.75M28.7M
Other Income / Expenses(17.12M)(14.63M)(13.02M)(9.75M)(113.37M)
Income Before Tax63.63M141.4M151.87M212.07M128.03M
Pre-Tax Margin6.4%12.1%11.6%15.6%9.6%
Income Tax Expense20.25M26M34.31M44.39M30.72M
Net Income43.38M115.4M117.56M167.68M97.31M
Net Margin4.4%9.9%9.0%12.3%7.3%
EPS (Basic)0.852.272.323.312.05
EPS (Diluted)0.842.242.293.312.05
Weighted Avg Shares51.05M50.78M50.71M50.33M47.18M
Weighted Avg Shares (Diluted)51.35M51.42M51.4M50.73M47.35M

Haemonetics Corporation

NYSE:HAE

Intrinsic Alpha fair value

Locked

Current Price

$122.86

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.